HIV SeropositivityHIV SeroprevalenceHIV InfectionsSubstance Abuse, IntravenousSexual BehaviorRisk FactorsSeroepidemiologic StudiesIncidenceAntibodies, ViralAntibodies, BacterialChlamydophila pneumoniaeAcquired Immunodeficiency SyndromeImmunoglobulin GPrevalenceChlamydophila InfectionsSerologic TestsEnzyme-Linked Immunosorbent AssayHIV SeronegativityHelicobacter pyloriHelicobacter InfectionsCohort StudiesToxocariasisProspective StudiesCytomegalovirus InfectionsAIDS SerodiagnosisCross-Sectional StudiesAntibodies, ProtozoanHIV-1Case-Control StudiesToxoplasmosisRetrospective StudiesAge DistributionHerpesvirus 2, HumanRural PopulationBlood DonorsToxocaraBrazilHepatitis CHomosexualityPapillomavirus InfectionsTime FactorsAIDS-Related Opportunistic InfectionsOdds RatioInfant, NewbornSyphilisUnited StatesNeosporaCytomegalovirusHerpes GenitalisFollow-Up StudiesCD4 Lymphocyte CountAnti-HIV AgentsImmunoglobulin AIndiaToxoplasmaHepatitis AHomosexuality, MalePregnancySexual PartnersRisk-TakingImmunoglobulin MLogistic ModelsHepatitis A Virus, HumanHuman papillomavirus 16Hepatitis B